<i>Helicobacter pylori</i> Infection Is Associated with Type 2 Diabetes, Not Type 1 Diabetes: An Updated Meta-Analysis

Li, Jun-Zhen; Li, Jie-Yao; Wu, Ting-Feng; Xu, Ji-Hao; Huang, Can-Ze; Cheng, Di; Chen, Qi-Kui; Yu, Tao

doi:https://doi.org/10.1155/2017/5715403

Gastroenterology Research and Practice

On this page

Abstract Introduction Methods Results Discussion Abbreviations Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Review Article | Open Access

Volume 2017 | Article ID 5715403 | https://doi.org/10.1155/2017/5715403

Helicobacter pylori Infection Is Associated with Type 2 Diabetes, Not Type 1 Diabetes: An Updated Meta-Analysis

Jun-Zhen Li,¹Jie-Yao Li,¹Ting-Feng Wu,¹Ji-Hao Xu,¹Can-Ze Huang,¹Di Cheng,¹Qi-Kui Chen,¹and Tao Yu¹

Academic Editor: Paul Enck

Received09 Jan 2017

Accepted14 May 2017

Published13 Aug 2017

Abstract

Background. Extragastric manifestations of Helicobacter pylori (H. pylori) infection have been reported in many diseases. However, there are still controversies about whether H. pylori infection is associated with diabetes mellitus (DM). This study was aimed at answering the question. Methods. A systematic search of the literature from January 1996 to January 2016 was conducted in PubMed, Embase databases, Cochrane Library, Google Scholar, Wanfang Data, China national knowledge database, and SinoMed. Published studies reporting H. pylori infection in both DM and non-DM individuals were recruited. Results. 79 studies with 57,397 individuals were included in this meta-analysis. The prevalence of H. pylori infection in DM group (54.9%) was significantly higher than that (47.5%) in non-DM group (OR = 1.69, ). The difference was significant in comparison between type 2 DM group and non-DM group (OR = 2.05), but not in that between type 1 DM group and non-DM group (OR = 1.23, 95% CI: 0.77–1.96, ). Conclusion. Our meta-analysis suggested that there is significantly higher prevalence of H. pylori infection in DM patients as compared to non-DM individuals. And the difference is associated with type 2 DM but not type 1 DM.

1. Introduction

Helicobacter pylori (H. pylori) is a gram-negative spiral bacterium, colonized in the stomach. Approximately one-half of the population over the world is infected with H. pylori [1]. Many researches have proved that H. pylori infection is highly associated with gastrointestinal diseases such as chronic gastritis, peptic ulcer disease, gastric cancer, and mucosa-associated lymphoid tissue (MALT) lymphoma since its discovery [2]. In addition, extragastric disorders associated with H. pylori infection, such as cardiovascular diseases and metabolic syndrome, have been revealed and some of them were characterized by persistent and low-grade systemic inflammation [3]. Inflammation has been demonstrated to play an important part in the pathogenesis of diabetes mellitus (DM), especially type 2 DM (T2DM) [4]. On the other hand, Kondrashova and Hyöty reviewed that some microbes served as the risk factor participating in the trigger and the development of type 1 DM (T1DM), but some microbes such as H. pylori served as a protective factor by lowering the risk of T1DM [5]. Above all, H. pylori infection was a factor not negligible in the process of DM.

Since Simon et al. firstly reported the association between H. pylori infection and DM [6], many studies were carried out. Several case-control studies have reported a higher prevalence of H. pylori infection in DM patients [7, 8]. Some cross-sectional researches also revealed a significant correlation between H. pylori infection and diabetes [9–11]. Moreover, a meta-analysis carried out by Zhou et al. suggested a trend toward more frequent H. pylori infection in DM patients, especially in T2DM patients [12]. However, Tamura et al. found a significantly higher DM prevalence among individuals with H. pylori infection than those without, but the difference could be mostly ascribed to older age [13]. And some studies argued that no difference in the prevalence of H. pylori infection was found between DM and non-DM individuals [14, 15]. Overall, this subject remains controversial now.

The present updated meta-analysis was conducted to answer if there is a difference in the prevalence of H. pylori infection between DM and non-DM individuals. Subgroup analyses were carried out based on the types of DM, geographical regions, and methods for H. pylori detection to further investigate the relationship between H. pylori infection and DM.

2. Methods

2.1. Search Strategy and Selection Criteria

Published guidelines for conducting meta-analyses were followed [16]. We searched PubMed, Embase databases, Cochrane Library, Google Scholar, Wanfang Data (Chinese), China national knowledge database (Chinese), and SinoMed (Chinese) for all relevant articles reported from January 1996 to January 2016, with combinations of the search terms “Helicobacter pylori,” or “H. pylori,” or “Campylobacter pylori,” or “C. pylori,” and “diabetes mellitus,” or “diabetes,” or “type 1 diabetes,” or “type 1 diabetes mellitus,” or “type 2 diabetes” or “type 2 diabetes mellitus”.

To be eligible for inclusion, studies had to meet the following criteria: (1) they were published studies which reported H. pylori infection in DM individuals and non-DM individuals (individuals without DM, impaired glucose tolerance, or impaired fasting glucose); (2) detailed data of H. pylori infection rate in both groups was provided. Studies that did not meet the inclusion criteria were not enrolled.

Studies were excluded if they were as follows: (1) duplicate publications; (2) case report, review, meta-analysis, or guideline; (3) not reporting clinically relevant outcomes; and (4) not providing enough details.

2.2. Data Extraction and Quality Assessment

Data were extracted by one investigator, verified by another investigator, and recorded in a well-designed form developed for this study. The data items included authors, year of publication, country, study design, methods of H. pylori detection, strains of H. pylori, types of DM, age, and sample size. The Newcastle-Ottawa scale (NOS) scoring system was used to assess the quality of the studies [17].

2.3. Statistical Analysis

To obtain pooled effect estimates, the random effects model or fixed effects model was used for meta-analysis, according to the heterogeneity among studies. If there was no statistically significant heterogeneity (two-tailed value >0.05) among the pooled studies, the fixed effect model would be applied; otherwise, the random effect model would be applied [18]. Odds ratio (OR) with 95% confidence interval (CI) was used for the case-control and cross-sectional studies, while risk ratio (RR) was for the cohort studies. The presence of between-study heterogeneity was estimated using Q-test and I² statistics. Sources of heterogeneity were explored by conducting subgroup analyses based on types of DM, geographical regions, and methods of H. pylori detection. The two-sided tests with significance level of 0.05 were conducted in pooled analyses and subgroup analyses using RevMan software (Version 5.3 for Windows, Cochrane Collaboration, Oxford, UK). Publication bias was evaluated graphically by the funnel plots and statistically by Begg’s test and Egger’s test with the STATA software (Version 14.0; STATA Corporation, College Station, TX, US). Pr and value less than 0.05 were considered representative of no statistically significant publication bias. If publication bias was indicated, the trim and fill method procedure was performed to identify and correct the publication bias [19]. The basis of the method was to (1) “trim” (remove) the studies causing funnel plot asymmetry, (2) use the trimmed funnel plot to estimate the true “centre” of the funnel, and then (3) replace the removed studies and their missing “counterparts” around the centre (filling). An estimate of the number of missing studies was provided; an adjusted OR is derived by performing a meta-analysis including the filled studies.

3. Results

3.1. Description of Studies

A total of 783 studies were retrieved from PubMed, Embase databases, Cochrane Library, Google Scholar, Wanfang Data (Chinese), China national knowledge database (Chinese), and SinoMed (Chinese). According to the criteria for inclusion and exclusion, 79 studies were included in this meta-analysis (Figure 1). The included study characteristics were summarized in Table 1. All of the articles were qualified to be pooled with quality score of NOS over 5. 76 studies were either case-control or cross-sectional studies, and 3 were prospective cohort ones.

A total of 57,397 individuals were enrolled in these studies, with a total H. pylori infection prevalence of 49.7% (28,542/57,397). The pooled H. pylori infection rate was 54.9% (9434/17,187) in DM group and 47.5% (19,108/40,210) in non-DM group. The OR was 1.69 (95% CI: 1.47–1.95, ) for the two groups. There was high heterogeneity among the studies (). The forest plot for pooled prevalence is showed in Figure 2. Each study was sequentially removed from the analysis, and the adjusted ORs (1.63–1.73) were approximate to the initial ones. Especially, the study of Han et al. [20] recruited a total of 6395 patients in DM group and 24,415 in non-DM group, which accounted for nearly one-third of the enrolled individuals in this analysis. However, after removing the data of Han et al. and re-analyzing, the adjusted odds (OR = 1.71) and heterogeneity () were still approximate to the initial ones in spite of its overweight scale.

3.2. Subgroup Analysis

We found a significant association between H. pylori infection and DM but the pooled analysis was with high heterogeneity (). Subgroup analyses based on the types of DM, geographical regions, and methods for H. pylori detection were conducted to detect the sources of heterogeneity. (1)Types of DM

12 studies with 3175 individuals were assigned to the T1DM subgroup, while 42 studies with 41,684 individuals were to the T2DM subgroup. No significant difference was found between T1DM group and non-DM group in H. pylori infection rate (OR = 1.23, 95% CI: 0.77–1.96, ; Figure 3). On the contrary, the pooled data indicated that the prevalence of H. pylori infection in T2DM was significantly higher than that in non-DM group (OR = 2.05, 95% CI: 1.67–2.52, ; Figure 3). Each study including the study by Han et al. with overweight scale was sequentially removed in the subgroups and the adjusted ORs (1.93–2.10 in T2DM and 1.10–1.42 in T1DM) approximated to the initial ones. (2)Geographical regions

Subgroup studies stratified by geographical regions were performed. The recruited individuals were mostly from Asia (75.8%, 43,523/57,397). The infection rate was 51.7% (22,503/43,523), 39.7% (2969/7479), 47.3% (2562/5411), and 48.7% (499/1024) in group Asia, group Europe, group America, and group Africa, respectively. No significant difference of H. pylori infection rate between DM and non-DM individuals was found in group America and group Africa ( for America; for Africa). However, in group Asia and group Europe, significantly higher H. pylori infection rate was detected in DM individuals (OR = 2.04 and OR = 1.40, resp.). But there was still high heterogeneity within these subgroups (; Figure 4). (3)Methods for H. pylori detection

Figure 4

Forest plot for subgroup analysis based on geographic regions. (India, Japan, China, Qatar, Pakistan, Saudi Arabia Iran, Hong Kong, and Taiwan were included in group Asia. Greece, Turkey, Italy, Poland, Romania, Belgium, Spain, Croatia, Israel, UK, and Czech Republic were included in group Europe, as well as Australia because it comprises similar races and people who lived in similar lifestyle with these countries. Brazil and USA were included in group America. Egypt and Nigeria were included in group Africa.)

Methods for H. pylori detection displayed different power in accuracy, which consequently might affect the detection rate of H. pylori infection. Methods for diagnosis of H. pylori were classified as invasive tests and noninvasive tests [21]. Invasive tests included rapid urease test, histology, and culture, and the noninvasive tests included ¹³C or ¹⁴C urea breath test, stool antigen detection, and serological approaches for antibodies of H. pylori. For the serological tests of anti-H. pylori IgG or/and IgA antibody in serum, high rates of false-positive results may happen and they cannot identify the differences between the current infection and past infection [21, 22]. So we typically sorted the studies with detection method of serological test into one subgroup and others into the other subgroup as they could identify the current infection precisely.

The studies of current infection group comprised of 51 articles and showed a significant higher prevalence of H. pylori infection in DM patients as compared to that in non-DM individuals with OR = 1.92 (95% CI: 1.57–2.34, ). Similarly, by enrolling 21 articles in serological test group, we found that the infection rate was 53.7% (1956/3640) in DM group while 46.4% (4097/8829) in the non-DM one (OR = 1.40, 95% CI: 1.10–1.79, ; Figure 5). The heterogeneities in both groups were high among studies with and , respectively (Figure 5).

3.3. Publication Bias

Funnel plot analysis did not show significant evidences of publication bias (Figure 6). Most of the studies were concentrated symmetrically. No significant publication bias was detected by Begg’s test with Pr = 0.411 but a significant bias was detected by Egger’s test with (Figure 7). As Egger’s test indicated the possibility of publication bias, the trim and fill method procedure was performed to identify and correct the publication bias. There was 14 hypothetical missing studies indicated by the trim and fill procedure, and the imputed pooled estimate was 1.366 (95% CI: 1.181–1.580, ). There still existed a statistically significant association between H. pylori infection and DM after adjusting for the publication bias, which suggested that our result was credible. Adjusted funnel plot by the trim and fill method was symmetrical and shown in Figure 8.

4. Discussion

DM is a chronic disease characterized by a long-term inflammation mechanism. Guo et al. demonstrated that diabetes was a risk factor for H. pylori infection [23]. Several meta-analyses aiming to investigate the association between H. pylori infection and DM have been carried out. Zhou et al. recruited 41 studies involving 14,080 patients, and the analysis reported higher risk of H. pylori infection among DM patients with OR = 1.33 (95% CI: 1.08–1.64) [12]. Wang et al. retrieved 39 studies involving more than 20,000 participants, with the OR = 1.59 (95% CI: 1.33–1.90) [24]. Our meta-analysis was an updated one and included more studies and individuals. Consistently, we found that the prevalence of H. pylori infection was significantly higher in DM patients. But we brought more robust result with higher OR (OR = 1.69, 95% CI: 1.47–1.95; Figure 2). Moreover, we explored more databases and recruited 25 studies reported in Chinese with high-quality score of NOS (all of them were >5). In addition, in subgroup analysis, we found no significant difference in prevalence of H. pylori infection in comparison between T1DM patients and non-DM people, which was inconsistent with what was reported by Wang et al. In a subgroup analysis of geographical regions, we found significant higher H. pylori infection rate among DM individuals in group Asia and group Europe but not in group Africa or group America. It was inconsistent with the Zhou et al. study which reported that the H. pylori effect only happened in Asian people. In this meta-analysis, we found no publication bias with Begg’s test, while Egger’s test showed a possibility of publication bias. But we performed the trim and fill method and found 14 hypothetical missing studies. The imputed pooled result still supported our original one. Therefore, no publication bias was shown in our meta-analysis and the result we got was credible. In this meta-analysis, the study of Han et al., even though with a total of 30,810 participants, did not affect the significance of the pooled results. Maybe it was because the other studies recruited as enough individuals (a total of 26,587 participants) as to be commensurate to the scale of the Han et al. study. Furthermore, the quality score of NOS for the study Han et al. was 9, which was high. Hence, despite the overweight scale, the study of Han et al. should not be neglected.

We found that there existed an association between H. pylori infection and DM in this meta-analysis. Several possible mechanisms might explain the association. Hyperglycemic condition in diabetic individuals could result in immune dysfunction, including damage to the neutrophil function, depression of antioxidant system, and impaired humoral immunity [25]. Moreover, abnormal enteric neuropathy caused by high blood sugar can modulate immune-cell function and stimulate proinflammatory cytokine production, resulting in neurodegeneration [26]. It leads to delay gastric emptying and lacking of acid secretion, which promotes bacterial colonization or overgrowth in gastrointestinal tract [27]. On the other hand, H. pylori infection in diabetic patients may worsen glycemic control [28], which leads to the difficulty of DM treatment, forming the vicious circle.

In this meta-analysis, we found that DM patients had a higher prevalence of H. pylori infection. But we could not come to the result whether and what role H. pylori infection plays on the pathogenesis or development of DM. It was reported that patients could be coinfected with H. pylori and some other pathogens like herpes simplex virus 1, cytomegalovirus, and Epstein-Barr virus, some of whom were also associated with DM [29–31]. But the number of researches on this issue was limited. We could not know whether other pathogens affect the effect of H. pylori on DM, either. Jeon et al. firstly carried out a prospective cohort study of 782 Latino elderly aged > 60 years and diabetes-free [32]. After following up over 10 years, the authors demonstrated that H. pylori seropositive patients experienced a greater rate of incident DM than individuals without DM (hazard ratio 2.69, 95% CI: 1.10–6.60), whereas those who were seropositive for herpes simplex virus 1, varicella virus, cytomegalovirus, and Toxoplasma. gondii did not show an increased rate of DM. It indicated that H. pylori infection might play an unknown role in the pathogenesis of DM, which implicated a potential step for preventing DM by eradication of H. pylori infection. Moreover, it also suggested that other pathogens such as cytomegalovirus and herpes simplex virus 1 might not have the similar effect on the DM like H. pylori. But our meta-analysis just revealed the association between H. pylori and DM, but could not suggest the effect of H. pylori on DM pathogenesis. More researches are needed to find out the actually effect of H. pylori infection on DM.

In subgroup analysis based on the types of DM, we demonstrated that 56.5% T2DM individuals were infected with H. pylori, but only 36.2% T1DM carried the bacterium (Figure 3). T2DM was more significantly prone to the infection of H. pylori. As to T2DM, insulin resistant (IR) is one of its characteristics. Aydemir et al. showed that IR was significantly higher in H. pylori infection group [33]. And Eshraghian et al. also supported that H. pylori infection was a risk factor for IR [34, 35]. Furthermore, it was reported that IR in T2DM patients could be improved after successful eradication of H. pylori [4]. It might partly explain the higher H. pylori infection rate in T2DM patients. On the other hand, we found no significant difference in prevalence of H. pylori infection in comparison between T1DM patients and non-DM people (), consistently with the report by Candelli et al. [27]. Whether this outcome is caused by the different pathogenesis or the onset age of T1DM and T2DM remains unclear. In the T1DM group, the mean age in most studies was not over 20, except for the studies of De Block et al. [36] and Sfarti et al. [37], while in T2DM group, the mean age was usually over 50 years old (Table 1). Epidemiological studies suggested that the prevalence of H. pylori infection increases with age [34]. As T1DM mainly onsets during childhood or young age, T1DM patients probably have less chance to be exposed to H. pylori infection. Consistently, Krause et al. showed a significantly lower positive rate of antibodies against H. pylori in T1DM patients [38]. But some studies held the contrary view that T1DM individuals were also prone to H. pylori infection [39, 40]. However, our meta-analysis with pooled estimate favored that T2DM rather than T1DM was associated with H. pylori infection. But the sample size of T1DM subgroup was not as large as that of T2DM. Larger sample size is needed to further verify the association between H. pylori infection and DM, especially T1DM.

The prevalence of H. pylori infection varies in different regions. We found significant higher H. pylori infection rate among DM individuals in group Asia and group Europe but not in group Africa or group America (Figure 4). Firstly, it was to be noted that there were much bigger sample size in group Asia and group Europe, respectively. This might be due to the more accurate detection methods and in group Africa and group America; the sample size might be too small to draw robust conclusion. Secondly, it might be explained by that the condition of medical care in developing countries from group Asia was too poor for DM patients to get good control of DM and prevent infectious complications. On the other hand, the epidemiology and different strains of H. pylori infection might attribute to the part of the result. Epidemiology studies revealed that almost all the Asians are infected with the strain of H. pylori carrying cytotoxin-associated gene A (CagA) but only nearly 60% of western people carried this stain [41, 42]. It was reported that H. pylori infection in Asians was predominated by CagA iceA1 genotypes while Americans and Africans by CagA iceA2 genotypes [41, 43]. CagA is a major virulence factor of H. pylori and has been reported to be associated with diabetic complications [44]. CagA-positive strain of H. pylori could cause poor glycemic control in T2DM and difficulty in eradication, which might result in the visible H. pylori effect among Asian but not African DM patients. However, due to the lack of data, we could not carry out the subgroup analysis based on different strains of H. pylori.

A number of testing methods are available for H. pylori detection. Serological test, namely, anti-H. pylori IgG and/or IgA test, is not affected by acid suppression therapy or recent antibiotic use. But seropositivity could not confirm current H. pylori infection, and anti-H. pylori IgG titre usually remains elevated for a long period even after clearance or eradication. Some study using anti-H. pylori IgG as the diagnosis of H. pylori infection might overestimate the infection rate. We typically conducted the analysis of serological test group and current infection group and found that in both subgroups, DM patients had higher prevalence of H. pylori infection than non-DM people (Figure 5). As a result, the association between H. pylori infection and DM was verified despite of different methods for H. pylori detection.

Despite the robust result, there existed limitations in our study. The studies were highly heterogeneous. Variables like age, sex, race, economic status, DM prevalence, and strains of H. pylori infection in the included studies varied. For the lack of enough detailed data, subgroup analysis stratified by age, sex, different stages of DM, and strains of H. pylori, which might bring up heterogeneity, could not be carried out. Furthermore, most of the articles meeting the inclusive criteria were case-control or cross-sectional ones, and only 3 were prospective ones. More well-designed and prospective cohort studies are needed for clarifying the association between H. pylori infection and DM.

In conclusion, despite the limitations, our meta-analysis suggested that there is significantly higher prevalence of H. pylori infection in DM when compared with the non-DM individuals. And the difference is associated with type 2 DM but not type 1 DM.

Abbreviations

H. pylori:	Helicobacter pylori
DM:	Diabetes mellitus
T2DM:	Type 2 DM
T1DM:	Type 1 DM
NOS:	Newcastle-Ottawa scale
OR:	Odds ratio
CI:	Confidence interval
RR:	Risk ratio
IR:	Insulin resistant
CagA:	Cytotoxin-associated gene A
MALT:	Mucosa-associated lymphoid tissue.

Conflicts of Interest

The authors declare that they have no conflict of interest.

Authors’ Contributions

Jun-Zhen Li and Jie-Yao Li contributed equally to this work.

Acknowledgments

This study was supported by the National Natural Science Foundation of China (no. 81270442 and no. 81370475).

References

World Gastroenterology Organisation, “World Gastroenterology Organisation Global Guideline: Helicobacter pylori in developing countries,” Journal of Clinical Gastroenterology, vol. 45, no. 5, pp. 383–388, 2011.
View at: Google Scholar
F. Franceschi, G. Zuccalà, D. Roccarina, and A. Gasbarrini, “Clinical effects of Helicobacter pylori outside the stomach,” Nature Reviews Gastroenterology & Hepatology, vol. 11, no. 4, pp. 234–242, 2014.
View at: Publisher Site | Google Scholar
F. Franceschi, A. Gasbarrini, S. A. Polyzos, and J. Kountouras, “Extragastric diseases and Helicobacter pylori,” Helicobacter, vol. 20, Supplement 1, pp. 40–46, 2015.
View at: Publisher Site | Google Scholar
L. R. Malamug, R. Karnchanasorn, R. Samoa, and K. C. Chiu, “The role of Helicobacter pylori seropositivity in insulin sensitivity, beta cell function, and abnormal glucose tolerance,” Scientifica (Cairo), vol. 2014, Article ID 870165, 7 pages, 2014.
View at: Publisher Site | Google Scholar
A. Kondrashova and H. Hyöty, “Role of viruses and other microbes in the pathogenesis of type 1 diabetes,” International Reviews of Immunology, vol. 33, no. 4, pp. 284–295, 2014.
View at: Google Scholar
L. Simon, J. Tornóczky, M. Tóth, M. Jámbor, and Z. Sudár, “The significance of Campylobacter pylori infection in gastroenterologic and diabetic practice,” Orvosi Hetilap, vol. 130, no. 25, pp. 1325–1329, 1989.
View at: Google Scholar
Y. Kayar, Ö. Pamukçu, H. Eroğlu, K. Kalkan Erol, A. Ilhan, and O. Kocaman, “Relationship between Helicobacter pylori infections in diabetic patients and inflammations, metabolic syndrome, and complications,” International Journal of Chronic Diseases, vol. 2015, Article ID 290128, 6 pages, 2015.
View at: Publisher Site | Google Scholar
B. R. Devrajani, S. Z. Shah, A. A. Soomro, and T. Devrajani, “Type 2 diabetes mellitus: a risk factor for Helicobacter pylori infection: ahospital based case-control study,” International Journal of Diabetes in Developing Countries, vol. 30, no. 1, pp. 22–26, 2010.
View at: Publisher Site | Google Scholar
S. Bajaj, L. Rekwal, S. P. Misra, V. Misra, R. K. Yadav, and A. Srivastava, “Association of helicobacter pylori infection with type 2 diabetes,” Indian Journal of Endocrinology and Metabolism, vol. 18, no. 5, pp. 694–699, 2014.
View at: Google Scholar
J. Vafaeimanesh, M. Parham, and M. Bagherzadeh, “Helicobacter pylori infection prevalence: is it different in diabetics and nondiabetics?” Indian Journal of Endocrinology and Metabolism, vol. 19, no. 3, pp. 364–368, 2015.
View at: Publisher Site | Google Scholar
G. H. Yang, J. S. Wu, Y. C. Yang, Y. H. Huang, F. H. Lu, and C. J. Chang, “Gastric Helicobacter pylori infection associated with risk of diabetes mellitus, but not prediabetes,” Journal of Gastroenterology and Hepatology, vol. 29, no. 10, pp. 1794–1799, 2014.
View at: Publisher Site | Google Scholar
X. Zhou, C. Zhang, J. Wu, and G. Zhang, “Association between Helicobacter pylori infection and diabetes mellitus a meta-analysis of observational studies,” Diabetes Research and Clinical Practice, vol. 99, no. 2, pp. 200–208, 2013.
View at: Publisher Site | Google Scholar
T. Tamura, E. Morita, S. Kawai et al., “No association between Helicobacter pylori infection and diabetes mellitus among a general Japanese population: a cross-sectional study,” SpringerPlus, vol. 4, p. 602, 2015.
View at: Publisher Site | Google Scholar
F. Zhou, X. Zhong, J. Chen et al., “Helicobacter pylori infection associated with type 2 diabetic nephropathy in patients with dyspeptic symptoms,” Diabetes Research and Clinical Practice, vol. 110, no. 3, pp. 328–334, 2015.
View at: Publisher Site | Google Scholar
N. Sotuneh, S. R. Hosseini, J. Shokri-Shirvani, A. Bijani, and R. Ghadimi, “Helicobacter pylori infection and metabolic parameters: is there an association in elderly population?” International Journal of Preventive Medicine, vol. 5, no. 12, pp. 1537–1542, 2014.
View at: Google Scholar
M. K. Swartz, “The PRISMA statement: a guideline for systematic reviews and meta-analyses,” Journal of Pediatric Health Care, vol. 25, no. 1, pp. 1-2, 2011.
View at: Google Scholar
G. A. Wells, B. Shea, D. O'Connell et al., The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses, Department of Epidemiology and Commuunity Medicine, University of Ottawa, http://www.ohri.ca/programs/clinical_epidemiology/oxford.Asp.
R. Simonian and N. Laird, “Meta-analysis in clinical trials,” Controlled Clinical Trials, vol. 7, no. 3, pp. 177–188, 1986.
View at: Google Scholar
S. Duval and R. Tweedie, “Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis,” Biometrics, vol. 56, no. 2, pp. 455–463, 2000.
View at: Google Scholar
X. Han, Y. Li, J. Wang et al., “Helicobacter pylori infection is associated with type 2 diabetes among a middle- and old-age Chinese population,” Diabetes/Metabolism Research and Reviews, vol. 32, no. 1, pp. 95–101, 2016.
View at: Publisher Site | Google Scholar
A. Mentis, P. Lehours, and F. Mégraud, “Epidemiology and diagnosis of Helicobacter pylori infection,” Helicobacter, vol. 20, Supplement 1, pp. 1–7, 2015.
View at: Google Scholar
B. Braden, “Diagnosis of Helicobacter pylori infection,” BMJ, vol. 344, article e828, 2012.
View at: Google Scholar
X. Guo, B. H. Zhao, and M. X. Zhang, “Risk factors of Helicobacter pylori infection among adults in northern China,” Hepato-Gastroenterology, vol. 58, no. 106, pp. 306–310, 2011.
View at: Google Scholar
F. Wang, J. Liu, and Z. Lv, “Association of Helicobacter pylori infection with diabetes mellitus and diabetic nephropathy: a meta-analysis of 39 studies involving more than 20,000 participants,” Scandinavian Journal of Infectious Diseases, vol. 45, no. 12, pp. 930–938, 2013.
View at: Google Scholar
A. Y. Peleg, T. Weerarathna, J. S. McCarthy, and T. M. Davis, “Common infections in diabetes: pathogenesis, management and relationship to glycaemic control,” Diabetes/Metabolism Research and Reviews, vol. 23, no. 1, pp. 3–13, 2007.
View at: Google Scholar
C. T. Brown, A. G. Davis-Richardson, A. Giongo et al., “Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes,” PloS One, vol. 6, article e25792, 2011.
View at: Publisher Site | Google Scholar
M. Candelli, D. Rigante, G. Marietti et al., “Helicobacter pylori, gastrointestinal symptoms, and metabolic control in young type 1 diabetes mellitus patients,” Pediatrics, vol. 111, 4, Part 1, pp. 800–803, 2003.
View at: Publisher Site | Google Scholar
C. Horikawa, S. Kodama, K. Fujihara et al., “Association of Helicobacter pylori infection with glycemic control in patients with diabetes: a meta-analysis,” Journal of Diabetes Research, vol. 2014, Article ID 250620, 7 pages, 2014.
View at: Publisher Site | Google Scholar
L. Baccaglini, V. J. Schoenbach, C. Poole et al., “Association between herpes simplex virus type 1 and Helicobacter pylori in US adolescents,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 101, no. 1, pp. 63–69, 2006.
View at: Publisher Site | Google Scholar
J. Zhang, Y. Y. Liu, H. L. Sun et al., “High human cytomegalovirus IgG level is associated with increased incidence of diabetic atherosclerosis in type 2 diabetes mellitus patients,” Medical Science Monitor, vol. 21, pp. 4102–4110, 2015.
View at: Google Scholar
S. Singh and H. C. Jha, “Status of Epstein-Barr virus coinfection with Helicobacter pylori in gastric cancer,” Journal of Oncology, vol. 2017, Article ID 3456264, 17 pages, 2017.
View at: Publisher Site | Google Scholar
C. Y. Jeon, M. N. Haan, C. Cheng et al., “Helicobacter pylori infection is associated with an increased rate of diabetes,” Diabetes Care, vol. 35, no. 3, pp. 520–525, 2012.
View at: Publisher Site | Google Scholar
S. Aydemir, T. Bayraktaroglu, M. Sert et al., “The effect of Helicobacter pylori on insulin resistance,” Digestive Diseases and Sciences, vol. 50, no. 11, pp. 2090–2093, 2005.
View at: Google Scholar
A. Eshraghian, S. A. Hashemi, A. Hamidian Jahromi et al., “Helicobacter pylori infection as a risk factor for insulin resistance,” Digestive Diseases and Sciences, vol. 54, no. 9, pp. 1966–1970, 2009.
View at: Publisher Site | Google Scholar
R. E. Pounder and D. Ng, “The prevalence of Helicobacter pylori infection in different countries,” Alimentary Pharmacology & Therapeutics, vol. 9, Supplement 2, pp. 33–39, 1995.
View at: Google Scholar
C. E. Block, I. H. Leeuw, J. J. Bogers et al., “Helicobacter pylori, parietal cell antibodies and autoimmune gastropathy in type 1 diabetes mellitus,” Alimentary Pharmacology & Therapeutics, vol. 16, no. 2, pp. 281–289, 2002.
View at: Google Scholar
C. Sfarti, A. Trifan, C. Hutanasu, C. Cojocariu, A. M. Singeap, and C. Stanciu, “Prevalence of gastroparesis in type 1 diabetes mellitus and its relationship to dyspeptic symptoms,” Journal of Gastrointestinal and Liver Diseases, vol. 19, no. 3, pp. 279–284, 2010.
View at: Google Scholar
I. Krause, J. M. Anaya, A. Fraser et al., “Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type I diabetes mellitus and their close family members,” Annals of the New York Academy of Sciences, vol. 1173, pp. 633–639, 2009.
View at: Publisher Site | Google Scholar
O. Senturk, Z. Canturk, B. Cetinarslan, C. Ercin, S. Hulagu, and N. Z. Canturk, “Prevalence and comparisons of five different diagnostic methods for Helicobacter pylori in diabetic patients,” Endocrine Research, vol. 27, no. 1-2, pp. 179–189, 2001.
View at: Google Scholar
M. M. El-Eshmawy, A. K. El-Hawary, S. S. Abdel Gawad, and A. A. El-Baiomy, “Helicobacter pylori infection might be responsible for the interconnection between type 1 diabetes and autoimmune thyroiditis,” Diabetology and Metabolic Syndrome, vol. 3, no. 1, p. 28, 2011.
View at: Publisher Site | Google Scholar
Y. Yamaoka, T. Kodama, O. Gutierrez, J. G. Kim, K. Kashima, and D. Y. Graham, “Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries,” Journal of Clinical Microbiology, vol. 37, no. 7, pp. 2274–2279, 1999.
View at: Google Scholar
T. Mizushima, T. Sugiyama, Y. Komatsu, J. Ishizuka, M. Kato, and M. Asaka, “Clinical relevance of the babA2 genotype of Helicobacter pylori in Japanese clinical isolates,” Journal of Clinical Microbiology, vol. 39, no. 7, pp. 2463–2465, 2001.
View at: Publisher Site | Google Scholar
M. Kidd, R. M. Peek, A. J. Lastovica, D. A. Israel, A. F. Kummer, and J. A. Louw, “Analysis of iceA genotypes in South African Helicobacter pylori strains and relationship to clinically significant disease,” Gut, vol. 49, no. 5, pp. 629–635, 2001.
View at: Google Scholar
A. Ibrahim, T. Zaher, T. A. Ghonemy, S. A. El-Azim, M. A. El-Azim, and A. Ramadan, “Impact of cytotoxin-associated gene A of Helicobacter pylori strains on microalbuminuria in type 2 diabetes,” Saudi Journal of Kidney Diseases and Transplantation, vol. 21, no. 4, pp. 694–700, 2010.
View at: Google Scholar
Y. Q. Qiao, Q. Wang, and J. X. Liu, “Helicobacter pylori infection in type 2 diabetes: 42 cases (Chinese),” Health Weekly, vol. 1, pp. 10-11, 2015.
View at: Google Scholar
S. W. Ji, H. Qu, C. L. Liu, Y. G. Zhang, and J. B. Wang, “Prevalence of Helicobacter pylori infection in 125 patients with type 2 diabetes and its effects on diabetic gastroparesis,” Chinese Journal of Digestion, vol. 6, pp. 377–381, 2015.
View at: Google Scholar
A. Chobot, K. Bak-Drabik, E. Skała-Zamorowska, A. Krzywicka, J. Kwiecień, and J. Polańska, “Helicobacter pylori infection in type 1 diabetes children and adolescents using ¹³C urea breath test,” Polish Journal of Microbiology, vol. 63, no. 1, pp. 63–67, 2014.
View at: Google Scholar
G. H. Zhang, Q. H. Yi, and J. Ma, “Helicobacter pylori infection in diabetes mellitus: 300 cases (Chinese),” Yunnan Medicine, vol. 3, pp. 388–390, 2014.
View at: Google Scholar
Y. N. Wei, H. L. Hei, W. Liu, X. Yang, L. J. Wang, and Y. Su, “The association between Helicobacter pylori infection and type 2 diabetes in the Han population in Henan province, China (Chinese),” Journal of Medical Forum, vol. 2, pp. 98-99, 2014.
View at: Google Scholar
L. Ye and G. Xu, “Helicobacter pylori infection in diabetic patients (Chinese),” Diabetes New World, vol. 10, p. 27, 2014.
View at: Google Scholar
J. X. Liu, X. Q. Zhang, G. Huang et al., “Study on the relationship between the infection of helicobacter pylori and carotid atherosclerosis in patients with type 2 diabetes,” Chinese Journal of Difficult and Complicated Cases, vol. 7, pp. 704–706, 2014.
View at: Google Scholar
W. H. Zhou, X. D. Mai, H. F. Lu, Y. H. Chen, K. W. Guo, and X. Long, “The correlation studies and clinical analysis of type 2 diabetes and Helicobacter pylori infection,” Journal of Taishan Medical College, vol. 8, pp. 738–740, 2014.
View at: Google Scholar
F. Wang and X. F. Wang, “The association between Helicobacter pylori infection and diabetes mellitus (Chinese),” Medical Information, vol. 5, 2014.
View at: Google Scholar
B. L. Bai, X. T. You, and P. Cao, “The correlation between Helicobacter pylori infection and diabetic peripheral neuropathy in type 2 diabetes (Chinese),” China Health Care & nutrition, vol. 24, no. 3, 2014.
View at: Google Scholar
A. H. Jia, Y. X. Liu, Y. Y. Li et al., “The analysis of necessity of Helicobacter pylori detection in type 2 diabetes (Chinese),” Practical Journal of Medicine & Pharmacy, vol. 31, no. 8, 2014.
View at: Google Scholar
A. Jafarzadeh, M. T. Rezayati, and M. Nemati, “Helicobacter pylori seropositivity in patients with type 2 diabetes mellitus in south-east of Iran,” Acta Medica Iranica, vol. 51, no. 12, pp. 892–896, 2013.
View at: Google Scholar
F. Keramat, S. H. Hashemi, A. Majlesi, S. Haddadinejad, A. M. Esfehani, and J. Poorolajal, “The association between diabetes mellitus and Helicobacter pylori infection,” International Journal of Diabetes in Developing Countries, vol. 33, no. 3, pp. 155–160, 2013.
View at: Google Scholar
C. J. Xue, Y. Chen, D. He, W. G. Zhong, and Y. Xia, “The association between Helicobacter pylori infection and type 2 diabetes (Chinese),” Continuing Medical Education, vol. 27, no. 10, pp. 27-28, 2013.
View at: Google Scholar
H. Luo, “49 cases on the analyses of Helicobacter pylori infection in diabetes with peptic ulcer (Chinese),” Shanxi Medical Journal, vol. 42, no. 5, 2013.
View at: Google Scholar
M. Candelli, D. Rigante, A. Schiavino et al., “High reinfection rate of Helicobacter pylori in young type 1 diabetic patients a three-year follow-up study,” European Review for Medical and Pharmacological Sciences, vol. 16, no. 11, pp. 1468–1472, 2012.
View at: Google Scholar
A. Oluyemi, E. Anomneze, S. Smith, and O. Fasanmade, “Prevalence of a marker of active helicobacter pylori infection among patients with type 2 diabetes mellitus in Lagos, Nigeria,” BMC Research Notes, vol. 5, p. 284, 2012.
View at: Google Scholar
Z. H. Hao, C. Y. Chen, J. M. Wang, H. Q. Chen, and Y. Li, “Helicobacter Pylori infection in patients with diabetes mellitus and the related factors of carotid atherosclerosis,” Chinese General Practice, vol. 15, no. 7, pp. 1914–1916, 2012.
View at: Google Scholar
Y. B. Xu, X. E. Yan, T. Yi, and M. F. Li, “The correlation between Helicobacter Pylori infection and diabetic retinopathy in type 2 diabetes (Chinese),” Medical Innovation of China, vol. 26, pp. 11-12, 2012.
View at: Google Scholar
Y. Wan, F. F. Zhang, and Q. Dong, “Infection of Helicobacter Pylori in type 2 diabetes (Chinese),” Clinical Journal of Medical Officers, vol. 39, no. 6, p. 1054, 2011.
View at: Google Scholar
S. Y. Chen, H. Lu, and S. Gao, “Diabetes mellitus with peptic ulcer: Clinic analysis of 62 cases,” Practical Journal of Clinical Medicine, vol. 08, no. 5, pp. 122–124, 2011.
View at: Google Scholar
R. P. Agrawal, R. Sharma, D. Garg, R. Pokharna, D. K. Kochar, and R. P. Kothari, “Role of Helicobacter pylori in causation of diabetic gastropathies and non-gastrointestinal complications in type 2 diabetes,” Journal of the Indian Medical Association, vol. 108, no. 3, pp. 140–143, 2010.
View at: Google Scholar
Y. G. Xu, X. Y. Liu, X. Y. Zhu, L. Guo, and S. Z. Wang, “Analysis of Helicobacter pylori infection status in type 2 diabetes mellitus,” Chinese Journal of Postgraduates of Medicine, vol. 33, no. 19, 2010.
View at: Google Scholar
V. L. Cabral, F. R. Patrício, M. A. Gabbay, S. A. Dib, and S. J. Miszputen, “Intraepithelial lymphocytes in duodenum from Brazilian adolescents with type 1 diabetes. Influence of Helicobacter pylori,” Pediatric Diabetes, vol. 10, no. 5, pp. 316–320, 2009.
View at: Publisher Site | Google Scholar
I. Ciortescu, C. Sfarti, M. Stan, M. Graur, and C. Stanciu, “Prevalence of Helicobacter pylori infection in patients with diabetes mellitus,” Revista Medico-Chirurgicala A Societatii de Medici si Naturalisti din Iasi, vol. 113, no. 4, pp. 1048–1055, 2009.
View at: Google Scholar
G. Lazaraki, J. Kountouras, S. Metallidis et al., “Endothelial nitric oxide synthase (eNOS) is not upregulated in gastric mucosa of Helicobacter pylori (H. pylori)-positive patients with type 2 diabetes mellitus,” Digestive and Liver Disease, vol. 41, no. 4, pp. 253–262, 2009.
View at: Publisher Site | Google Scholar
L. Q. Zhang and M. Q. Zhang, “Gastroparesis causing by Helicobacter pylori infection in type 2 diabetes (Chinese),” Chinese Journal of Prevention and Control of Chronic Diseases, vol. 17, no. 4, pp. 413-414, 2009.
View at: Google Scholar
X. J. Yu, “The association between H. pylori infection and type 2 diabetes (Chinese),” Modern Practical Medicine, vol. 21, no. 5, p. 481, 2009.
View at: Google Scholar
K. Ariizumi, T. Koike, S. Ohara et al., “Incidence of reflux esophagitis and H. pylori infection in diabetic patients,” World Journal of Gastroenterology, vol. 14, no. 20, pp. 3212–3217, 2008.
View at: Google Scholar
M. Demir, H. S. Gokturk, N. A. Ozturk, M. Kulaksizoglu, E. Serin, and U. Yilmaz, “Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications,” Digestive Diseases and Sciences, vol. 53, no. 10, pp. 2646–2649, 2008.
View at: Publisher Site | Google Scholar
S. A. Hamed, N. F. Amine, G. M. Galal et al., “Vascular risks and complications in diabetes mellitus: the role of helicobacter pylori infection,” Journal of Stroke and Cerebrovascular Diseases, vol. 17, no. 2, pp. 86–94, 2008.
View at: Publisher Site | Google Scholar
C. Nicholas, E. Ugwuja, B. N. Ejikeme, and N. C. Obeka, “Helicobacter pylori seropositivity in Nigerians with type 2 diabetes mellitus,” Internet Journal of Tropical Medicine, vol. 4, no. 2, 2008.
View at: Google Scholar
S. Q. Yan, J. F. Zhan, H. N. Tian, W. Tan, and H. Jin, “The association between H. pylori infection and type 2 diabetes (Chinese),” Journal of Practical Diabetology, vol. 4, no. 4, pp. 21-22, 2008.
View at: Google Scholar
D. Y. Wang, L. M. Zhou, and H. M. Tong, “Prevalence of Helicobacter pylori infection in type 2 diabetic mellitus patients with complicated peptic ulcer and effect of eradication,” Chinese Journal of Nosocomiology, vol. 10, pp. 2191–2193, 2015.
View at: Google Scholar
Y. F. Ji, C. F. Zhong, and S. J. Ji, “Clinical analyses on 120 cases of endoscopy in diabetic gastropathy patients (Chinese),” Chinese Journal of Postgraduates of Medicine, vol. 31, no. 16, 2008.
View at: Google Scholar
A. Bener, R. Micallef, M. Afifi, M. Derbala, H. M. Al-Mulla, and M. A. Usmani, “Association between type 2 diabetes mellitus and Helicobacter pylori infection,” The Turkish Journal of Gastroenterology, vol. 18, no. 4, pp. 225–229, 2007.
View at: Google Scholar
G. X. Sun, Y. J. Tan, and Y. L. Zhu, “The relationship between type 2 diabetes mellitus and H. pylori infection,” Journal of Practical Medical Techniques, vol. 14, no. 28, pp. 3868-3869, 2007.
View at: Google Scholar
S. M. Jaber, “Helicobacter pylori seropositivity in children with chronic disease in Jeddah, Saudi Arabia,” Saudi Journal of Gastroenterology, vol. 12, no. 1, pp. 21–26, 2006.
View at: Google Scholar
X. M. Lu, L. M. Chen, H. Yang, C. F. Ye, S. G. Yang, and M. Xiang, “Association of ischemic cardiocerebrovascular disease with Helicobacter pylori infection in patients with type 2 diabetes,” Chinese Journal of Endocrinology and Metabolism, vol. 22, no. 4, pp. 359-360, 2006.
View at: Google Scholar
N. E. Gulcelik, E. Kaya, B. Demirbas et al., “Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy,” Journal of Endocrinological Investigation, vol. 28, no. 3, pp. 214–217, 2005.
View at: Google Scholar
R. F. Gillum, “Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey,” Journal of the National Medical Association, vol. 96, no. 11, pp. 1470–1476, 2004.
View at: Google Scholar
R. Anastasios, C. Goritsas, C. Papamihail, R. Trigidou, P. Garzonis, and A. Ferti, “Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings,” European Journal of Internal Medicine, vol. 13, no. 6, p. 376, 2002.
View at: Google Scholar
S. Cenerelli, P. Bonazzi, R. Galeazzi et al., “Helicobacter pylori masks differences in homocysteine plasma levels between controls and type 2 diabetic patients,” European Journal of Clinical Investigation, vol. 32, no. 3, pp. 158–162, 2002.
View at: Google Scholar
C. Colombo, P. A. Tomasi, G. F. Meloni, A. M. Marinaro, A. Ogana, and T. Meloni, “Seroprevalence of Helicobacter pylori in children with type 1 diabetes mellitus in Sardinia,” Diabetes, Nutrition & Metabolism, vol. 15, no. 2, pp. 91–95, 2002.
View at: Google Scholar
S. Maule, L. Lombardo, C. Rossi et al., “Helicobacter pylori infection and gastric function in primary autonomic neuropathy,” Clinical Autonomic Research, vol. 12, no. 3, pp. 193–196, 2002.
View at: Google Scholar
J. Zelenková, A. Soucková, M. Kvapil, A. Soucek, J. Vejvalka, and J. Segethova, “Helicobacter pylori and diabetes mellitus,” Casopis lekaru ceskych, vol. 141, no. 18, pp. 575–577, 2002.
View at: Google Scholar
G. T. Ko, F. K. Chan, W. B. Chan et al., “Helicobacter pylori infection in Chinese subjects with type 2 diabetes,” Endocrine Research, vol. 27, no. 1-2, pp. 171–177, 2001.
View at: Google Scholar
A. Ivandić, D. Bozić, B. Dmitrović, A. Vcev, and S. Canecki, “Gastropathy and diarrhea in diabetic patients: the presence of helicobacteriosis and PAS-positive vascular deposits in gastric and duodenal mucosa,” Wiener Klinische Wochenschrift, vol. 113, no. 5-6, pp. 199–203, 2001.
View at: Google Scholar
M. Ravera, S. Bahenda, R. Owor, and R. Visonà, “Helicobacter pylori infection in diabetic patients with dyspepsia in Uganda,” Digestive and Liver Disease, vol. 33, no. 4, pp. 390-391, 2001.
View at: Google Scholar
M. Marrollo, G. Latella, D. Melideo et al., “Increased prevalence of Helicobacter pylori in patients with diabetes mellitus,” Digestive and Liver Disease, vol. 33, no. 1, pp. 21–29, 2001.
View at: Google Scholar
M. Quatrini, V. Boarino, A. Ghidoni, A. R. Baldassarri, P. A. Bianchi, and M. T. Bardella, “Helicobacter pylori prevalence in patients with diabetes and its relationship to dyspeptic symptoms,” Journal of Clinical Gastroenterology, vol. 32, no. 3, pp. 215–217, 2001.
View at: Google Scholar
A. Vazeou, A. Papadopoulou, I. W. Booth, and C. S. Bartsocas, “Prevalence of gastrointestinal symptoms in children and adolescents with type 1 diabetes,” Diabetes Care, vol. 24, no. 5, pp. 962–964, 2001.
View at: Google Scholar
H. H. Xia, N. J. Talley, E. P. Kam, L. J. Young, J. Hammer, and M. Horowitz, “Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus,” The American Journal of Gastroenterology, vol. 96, no. 4, pp. 1039–1046, 2001.
View at: Google Scholar
L. J. Zhao, “H. pylori infection and type 2 diabetes (Chinese),” Beijing Medical Journal, vol. 24, no. 1, pp. 60-61, 2002.
View at: Google Scholar
D. Arslan, M. Kendirci, S. Kurtoglu, and M. Kula, “Helicobacter pylori infection in children with insulin dependent diabetes mellitus,” Journal of Pediatric Endocrinology & Metabolism, vol. 13, no. 5, pp. 553–556, 2000.
View at: Google Scholar
M. P. Dore, M. Bilotta, H. M. Malaty et al., “Diabetes mellitus and Helicobacter pylori infection,” Nutrition, vol. 16, no. 6, pp. 407–410, 2000.
View at: Google Scholar
N. Güvener, Y. Akcan, I. Paksoy et al., “Helicobacter pylori associated gastric pathology in patients with type II diabetes mellitus and its relationship with gastric emptying: the Ankara study,” Experimental and Clinical Endocrinology & Diabetes, vol. 107, no. 3, pp. 172–176, 1999.
View at: Publisher Site | Google Scholar
S. Salardi, E. Cacciari, M. Menegatti et al., “Helicobacter pylori and type 1 diabetes mellitus in children,” Journal of Pediatric Gastroenterology and Nutrition, vol. 28, no. 3, pp. 307–309, 1999.
View at: Google Scholar
D. A. Luis, H. de la Calle, G. Roy et al., “Helicobacter pylori infection and insulin-dependent diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 39, no. 2, pp. 143–146, 1998.
View at: Google Scholar
A. Gasbarrini, V. Ojetti, D. Pitocco et al., “Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus,” European Journal of Gastroenterology & Hepatology, vol. 10, no. 6, pp. 469–472, 1998.
View at: Google Scholar
S. Gentile, S. Turco, B. Oliviero, and R. Torella, “The role of autonomic neuropathy as a risk factor of Helicobacter pylori infection in dyspeptic patients with type 2 diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 42, no. 1, pp. 41–48, 1998.
View at: Google Scholar
M. Pocecco, E. Buratti, A. Tommasini, G. Torre, and T. Not, “High risk of Helicobacter pylori infection associated with cow’s milk antibodies in young diabetics,” Acta Paediatrica, vol. 86, no. 7, pp. 700–703, 1997.
View at: Google Scholar
M. Małlecki, A. I. Bień, D. Galicka-Latałla, J. Stachura, and J. Sieradzki, “The prevalence of Helicobacter pylori infection and types of gastritis in diabetic patients. The Kraków Study,” Experimental and Clinical Endocrinology & Diabetes, vol. 104, no. 5, pp. 365–369, 1996.
View at: Google Scholar

Copyright

Copyright © 2017 Jun-Zhen Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

4337

Downloads

1652

Citations